Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Cyclerion Therapeutics (CYCN) Shares Issued (2019 - 2025)

Historic Shares Issued for Cyclerion Therapeutics (CYCN) over the last 5 years, with Q1 2025 value amounting to $1.4 million.

  • Cyclerion Therapeutics' Shares Issued changed N/A to $1.4 million in Q1 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $5.0 million for FY2023, which is 1714137.93% up from last year.
  • Cyclerion Therapeutics' Shares Issued amounted to $1.4 million in Q1 2025.
  • In the past 5 years, Cyclerion Therapeutics' Shares Issued registered a high of $30.5 million during Q2 2021, and its lowest value of $6000.0 during Q3 2021.
  • Moreover, its 3-year median value for Shares Issued was $701000.0 (2021), whereas its average is $7.4 million.
  • Data for Cyclerion Therapeutics' Shares Issued shows a peak YoY increase of 1968571.43% (in 2021) and a maximum YoY decrease of 9997.51% (in 2021) over the last 5 years.
  • Quarter analysis of 3 years shows Cyclerion Therapeutics' Shares Issued stood at $12.5 million in 2021, then tumbled by 99.86% to $17000.0 in 2022, then skyrocketed by 7988.24% to $1.4 million in 2025.
  • Its Shares Issued stands at $1.4 million for Q1 2025, versus $17000.0 for Q2 2022 and $12.5 million for Q4 2021.